COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort study
Top Cited Papers
- 1 September 2020
- journal article
- research article
- Published by Elsevier BV in The Lancet Child & Adolescent Health
- Vol. 4 (9), 653-661
- https://doi.org/10.1016/s2352-4642(20)30177-2
Abstract
No abstract availableFunding Information
- Instituto de Salud Carlos III
- Gilead Sciences
- European Regional Development Fund (JR16/00036)
- European Commission
- Departament de Salut, Generalitat de Catalunya (SLT008/18/00193)
- Consejería de Salud y Familias, Junta de Andalucía
- Deutsche Gesellschaft für Internationale Zusammenarbeit
- European Society of Clinical Microbiology and Infectious Diseases
This publication has 30 references indexed in Scilit:
- Tuberculosis Disease in Children and Adolescents on Therapy With Antitumor Necrosis Factor-ɑ Agents: A Collaborative, Multicenter Paediatric Tuberculosis Network European Trials Group (ptbnet) StudyClinical Infectious Diseases, 2019
- Use of Xpert MTB/RIF Ultra assays among paediatric tuberculosis experts in EuropeEuropean Respiratory Journal, 2018
- Characteristics and outcomes of a cohort hospitalized for pandemic and seasonal influenza in Germany based on nationwide inpatient dataPLOS ONE, 2017
- Protecting the Newborn and Young Infant from Infectious Diseases: Lessons from Immune OntogenyImmunity, 2017
- European shortage of purified protein derivative and its impact on tuberculosis screening practicesThe International Journal of Tuberculosis and Lung Disease, 2016
- Shortage of purified protein derivative for tuberculosis testingThe Lancet, 2014
- Availability and Use of Molecular Microbiological and Immunological Tests for the Diagnosis of Tuberculosis in EuropePLOS ONE, 2014
- High Flow Nasal Cannulae Therapy in Infants with BronchiolitisThe Journal of Pediatrics, 2010
- Neonatal Innate TLR-Mediated Responses Are Distinct from Those of AdultsThe Journal of Immunology, 2009
- Immunosenescence: a reviewArchives of Gerontology and Geriatrics, 2001